Development of stabilized glucomannosylated chitosan nanoparticles using tandem crosslinking method for oral vaccine delivery.
about
Synthetic Nanoparticles for Vaccines and ImmunotherapyTetanus toxoid-loaded layer-by-layer nanoassemblies for efficient systemic, mucosal, and cellular immunostimulatory response following oral administration.Development of dual toxoid-loaded layersomes for complete immunostimulatory response following peroral administration.Current state and challenges in developing oral vaccines.Recent developments in nanocarrier-aided mucosal vaccination.Anti-cancer efficacy of biotinylated chitosan nanoparticles in liver cancer.The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation.
P2860
Q28085375-665B50C8-0D38-495D-9862-2C4E3094B0C7Q38850944-09213C95-8DC7-4D22-B467-D1E5AC255318Q38880439-222B8053-B580-4896-8149-772CECC1C375Q39259629-D94F3C7C-776C-4CA0-B800-AE7D10D43E72Q40228907-67301853-3EDF-4F61-8743-221B105D3BDFQ41709085-B8BE6415-BD23-43C1-BC0A-8C7D89C673B1Q47449818-C56709FB-89FA-4C1C-BF36-88EA9D03F25C
P2860
Development of stabilized glucomannosylated chitosan nanoparticles using tandem crosslinking method for oral vaccine delivery.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Development of stabilized gluc ...... hod for oral vaccine delivery.
@en
Development of stabilized gluc ...... hod for oral vaccine delivery.
@nl
type
label
Development of stabilized gluc ...... hod for oral vaccine delivery.
@en
Development of stabilized gluc ...... hod for oral vaccine delivery.
@nl
prefLabel
Development of stabilized gluc ...... hod for oral vaccine delivery.
@en
Development of stabilized gluc ...... hod for oral vaccine delivery.
@nl
P2860
P356
P1433
P1476
Development of stabilized gluc ...... hod for oral vaccine delivery.
@en
P2093
Harshad Harde
Sanyog Jain
P2860
P304
P356
10.2217/NNM.13.225
P577
2014-11-01T00:00:00Z